An open-label study on the safety and immunogenicity of a PD-1-enhanced DNA vaccine used as a T cell booster for COVID-19.
Wong YC, Hang Ho DH, Zhou R, Zhang R, Woo KF, Cheng WY, Wang T, Du Y, Polly Pang KP, Tai WK, Jin X, Chen Z, Ngai Hung IF.
Wong YC, et al. Among authors: cheng wy.
EBioMedicine. 2025 May;115:105699. doi: 10.1016/j.ebiom.2025.105699. Epub 2025 Apr 16.
EBioMedicine. 2025.
PMID: 40245494
Free PMC article.
Clinical Trial.